Hearing Loss Proteins Do Double Duty - and That Second Job May Kill Hair Cells

Inside the inner ear, roughly 16,000 sensory hair cells convert the mechanical energy of sound into electrical impulses the brain can interpret. Each cell is topped with a bundle of microscopic projections that bend in response to vibration, opening ion channels and triggering a signal that travels toward the auditory cortex. Hair cells don't regenerate in mammals. Damage them, and the hearing loss is permanent.

Two proteins, TMC1 and TMC2, sit at the core of this process. They form the ion channels in hair cells that respond to sound-induced deflections, and mutations in TMC1 are among the most common genetic causes of inherited deafness. Scientists have studied these proteins for years as hearing machinery. A team at the National Institute on Deafness and Other Communication Disorders (NIDCD) at the National Institutes of Health has now discovered they do something else entirely - and that the second function may be the one that actually kills hair cells when things go wrong. The research was presented at the 70th Biophysical Society Annual Meeting in San Francisco in February 2026.

A Hidden Function in the Membrane

Cell membranes are not symmetric. Different types of phospholipid molecules are deliberately segregated to opposite faces of the bilayer. One phospholipid in particular, phosphatidylserine, is normally confined to the inner face of the membrane - the side facing the cell interior. When phosphatidylserine flips to the outer surface, it serves as a signal: the cell is dying. This flip is carried out by enzymes called lipid scramblases, which move phospholipids across the membrane.

The NIDCD team, led by Angela Ballesteros, discovered that TMC1 and TMC2 are lipid scramblases. That is not their established function, and the finding was unexpected. "We found that TMC1 and TMC2 are not only ion channels important for hearing - they also regulate the cell membrane," said Ballesteros. "And we think this membrane regulatory function, not the channel function, is what leads to hair cell death when things go wrong."

Membrane Collapse, Not Channel Failure

The evidence comes from mouse models carrying TMC1 mutations that cause deafness. In hair cells from these mice, the researchers observed phosphatidylserine appearing on the outer membrane surface - the hallmark of apoptosis, or programmed cell death. The membrane was also blebbing, forming bulging protrusions characteristic of dying cells.

"Hair cells from mouse models carrying mutations in TMC1 that cause hearing loss exhibit this membrane dysregulation - phosphatidylserine gets externalized, and the membrane starts blebbing and falling apart," Ballesteros said. "This is an apoptotic hallmark. It's what's killing the hair cells."

The implication is that deafness-causing TMC1 mutations may not primarily kill hair cells by disrupting sound transduction. They may instead trigger a collapse of membrane asymmetry that drives the cell toward death through an apoptotic pathway - a fundamentally different mechanism that points toward different potential interventions.

Aminoglycosides: A New Mechanism for an Old Problem

The findings also reframe a longstanding clinical mystery. Aminoglycoside antibiotics - drugs like gentamicin and streptomycin, which are widely used to treat serious bacterial infections - are known to damage hearing as a side effect. The standard explanation has been that they block the ion channel function of TMC proteins in hair cells.

Hubert Lee, a postdoctoral fellow in Ballesteros's lab and co-first author of the study, found evidence pointing in a different direction. In intact hair cells, aminoglycosides appear to activate the scramblase function of TMC proteins, triggering the same membrane asymmetry collapse seen in genetic mutations. "What we're seeing now is that in the chaotic environment of the living hair cell, these drugs act as potent disruptors, triggering a collapse of membrane asymmetry," Lee said.

The picture is complicated by the fact that when the team studied purified TMC proteins in reconstituted membrane systems - outside the cell - the proteins appeared indifferent to aminoglycosides. This suggests other factors, such as specific lipid compositions found only in hair cell membranes, or protein partners that are present in the cell but absent in the reconstituted system, are necessary for the drugs to activate the scramblase pathway.

Cholesterol as a Potential Target

The team also found that scramblase activity in TMC proteins depends on cholesterol levels in the membrane. This dependency is potentially significant: cholesterol is a known regulator of membrane physical properties and is itself influenced by diet and metabolism. If the scramblase pathway is cholesterol-dependent, then interventions targeting membrane cholesterol composition might offer a route to protecting hair cells from either genetic mutations or ototoxic drugs.

"If we understand the mechanism by which these drugs activate the scramblase, we might be able to design new drugs that lack this effect," said Yein Christina Park, a graduate student at the NIH-JHU program and co-first author of the work. "We could potentially have antibiotics that don't cause permanent hearing loss."

These possibilities remain speculative and face significant obstacles. The finding that aminoglycosides activate the scramblase only in intact cells, and not in reconstituted systems, suggests the full mechanism is complex and not yet fully understood. Mouse models, while informative, do not always translate directly to human hearing biology. And the therapeutic path from a mechanistic finding in hair cells to a drug that protects against ototoxicity is long. Still, identifying the membrane regulatory function of TMC proteins as a central driver of hair cell death gives researchers a concrete new target to investigate.